Lookers PLC
27 March 2006
FORM 8.1
DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES
FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
(Rules 8.1(a) and (b)(i) of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of person dealing (Note 1) DAVID JOHN BLAKEMAN
Company dealt in LOOKERS PLC
Class of relevant security to which the ORDINARY SHARES OF 25 PENCE EACH
dealings being disclosed relate (Note 2)
Date of dealing 24 MARCH 2006
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 135,163 0.3772
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total 135,163 0.3772
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
ORDINARY SHARES OF 25 PENCE EACH Grant of Option pursuant to Lookers Matching Shares Plan to subscribe
for 23,342 shares at nominal value from 24 March 2009 to 24 March
2016, subject to rules of plan and performance criteria
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
PURCHASE 11,671 707.7 pence
(b) Derivatives transactions (other than options)
Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)
e.g. CFD
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money
purchasing, to which the option American,
e.g. call option varying etc. relates (Note 7) price European etc. date paid/received per
unit (Note 5)
Grant of Option Grant 23,342 25 pence/ 24 March Nil
pursuant to Matching share 2016
Share Plan
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 24 MARCH 2006
Contact name DAVID BLAKEMAN
Telephone number 0161 291 0043
Name of offeree/offeror with which associated N/A
Specify category and nature of associate status (Note 10) N/A
Notes
The Notes on Form 8.1 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.